Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
3(33%)
Results Posted
50%(1 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_1
6
67%
Ph phase_4
1
11%
Ph phase_3
2
22%

Phase Distribution

6

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
6(66.7%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(2)
Terminated(2)
Other(2)

Detailed Status

Recruiting3
Terminated2
Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (66.7%)
Phase 32 (22.2%)
Phase 41 (11.1%)

Trials by Status

terminated222%
completed222%
unknown222%
recruiting333%

Recent Activity

3 active trials
Showing 5 of 9
recruitingphase_1

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

NCT06351592
recruitingphase_1

A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration

NCT06660667
recruitingphase_1

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

NCT06796686
terminatedphase_1

Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens

NCT05216510
unknownphase_1

Brain Insulin Resistance in Mood Disorders

NCT03915613
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06351592Phase 1

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

Recruiting
NCT06660667Phase 1

A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration

Recruiting
NCT06796686Phase 1

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

Recruiting
NCT05216510Phase 1

Assessment of Delayed-type Hypersensitivity Reactions to SARS-CoV-2 Peptide Antigens

Terminated
NCT03915613Phase 1

Brain Insulin Resistance in Mood Disorders

Unknown
NCT01862523Phase 4

Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and Controls

Completed
NCT00671593Phase 1

Differential Gene Expression in Lung and Peripheral Blood After Inhaled Allergen Challenge

Terminated
NCT01558466Phase 3

Sildenofil in Persistent Pulmonary Hypertension in Newborns

Unknown
NCT00314314Phase 3

The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder

Completed

All 9 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
9